{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:09:24Z","timestamp":1789204164335,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cct.2015.01.012","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T01:17:17Z","timestamp":1422407837000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy"],"prefix":"10.1016","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct02271893","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Elodie","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Villatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Delage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Dubray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2015.01.012_bb0005","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","author":"Ferlay","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cct.2015.01.012_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/14740338.2011.543417","article-title":"Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence","volume":"10","author":"Balayssac","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cct.2015.01.012_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.soncn.2007.05.001","article-title":"Peripheral neuropathy related to chemotherapy","volume":"23","author":"Wilkes","year":"2007","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.cct.2015.01.012_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.cct.2015.01.012_bb0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2325\/jbcs.12.279","article-title":"Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients\u2014evaluation of appropriate research design and methodology to measure symptoms","volume":"12","author":"Matsuda","year":"2005","journal-title":"Breast Cancer Tokyo Jpn"},{"key":"10.1016\/j.cct.2015.01.012_bb0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/annonc\/mdm500","article-title":"Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop","volume":"19","author":"Vardy","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cct.2015.01.012_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.critrevonc.2011.09.001","article-title":"Neuro-cognitive impairment in breast cancer patients: pharmacological considerations","volume":"83","author":"Cheung","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cct.2015.01.012_bb0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1037\/neu0000064","article-title":"A meta-analysis of cognitive impairment following adult cancer chemotherapy","volume":"28","author":"Lindner","year":"2014","journal-title":"Neuropsychology"},{"key":"10.1016\/j.cct.2015.01.012_bb0045","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","article-title":"Chemotherapy-induced neuropathy: a comprehensive survey","volume":"40","author":"Miltenburg","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cct.2015.01.012_bb0050","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2015.01.012_bb0055","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1526-4637.2010.00981.x","article-title":"NMDA receptor antagonists for the treatment of neuropathic pain","volume":"11","author":"Collins","year":"2010","journal-title":"Pain Med Malden Mass"},{"key":"10.1016\/j.cct.2015.01.012_bb0060","article-title":"The glutamatergic system: physiology and pharmacology of the NMDA receptor","volume":"XIV","author":"Pickering","year":"2010","journal-title":"Lett Neurol"},{"key":"10.1016\/j.cct.2015.01.012_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/ecp.11.17","article-title":"Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain","volume":"4","author":"Zhou","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.cct.2015.01.012_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1212\/WNL.48.5.1212","article-title":"High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia","volume":"48","author":"Nelson","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2015.01.012_bb0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","article-title":"Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials","volume":"96","author":"Sang","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cct.2015.01.012_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1526-4637.2011.01316.x","article-title":"Efficacy and safety of dextromethorphan\/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study","volume":"13","author":"Shaibani","year":"2012","journal-title":"Pain Med Malden Mass"},{"key":"10.1016\/j.cct.2015.01.012_bb0085","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.clinthera.2006.10.005","article-title":"Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-Label, dose-escalation study","volume":"28","author":"Thisted","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.cct.2015.01.012_bb0090","first-page":"45","article-title":"Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain","volume":"16","author":"Ehret","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.cct.2015.01.012_bb0095","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.0001-5172.2004.0325.x","article-title":"Analgesic effect of dextromethorphan in neuropathic pain","volume":"48","author":"Carlsson","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.cct.2015.01.012_bb0100","first-page":"145","article-title":"Postoperative intramuscular dextromethorphan injection provides pain relief and decreases opioid requirement after modified radical mastectomy","volume":"2","author":"Wu","year":"2000","journal-title":"Int J Surg Investig"},{"key":"10.1016\/j.cct.2015.01.012_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03019730","article-title":"Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia","volume":"48","author":"Weinbroum","year":"2001","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cct.2015.01.012_bb0110","first-page":"e11187","article-title":"Effects of preoperative use of oral dextromethorphan on postoperative need for analgesics in patients with knee arthroscopy","volume":"4","author":"Entezary","year":"2014","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.cct.2015.01.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.12076","article-title":"Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain","author":"Morel","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cct.2015.01.012_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1745-6215-15-331","article-title":"Prevention of post-mastectomy neuropathic pain with memantine: study protocol for a randomized controlled trial","volume":"15","author":"Pickering","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.cct.2015.01.012_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2008.01.007","article-title":"Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice","volume":"95","author":"Bisaga","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cct.2015.01.012_bb0130","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.lfs.2005.04.025","article-title":"Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil","volume":"77","author":"Marier","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.cct.2015.01.012_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0269881104047278","article-title":"P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6","volume":"18","author":"Uhr","year":"2004","journal-title":"J Psychophopharmacol Oxf Engl"},{"key":"10.1016\/j.cct.2015.01.012_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.cct.2015.01.012_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00000542-197101000-00017","article-title":"On the language of pain","volume":"34","author":"Melzack","year":"1971","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cct.2015.01.012_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000542-200507000-00028","article-title":"The McGill pain questionnaire: from description to measurement","volume":"103","author":"Melzack","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cct.2015.01.012_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/PMS.8.7.271-276","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.cct.2015.01.012_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail Making Test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol"},{"key":"10.1016\/j.cct.2015.01.012_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/geronj\/47.3.P121","article-title":"What do adult age difference in the Digit Symbol Substitution Test reflect?","volume":"47","author":"Salthouse","year":"1992","journal-title":"J Gerontol"},{"key":"10.1016\/j.cct.2015.01.012_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/00050069908257455","article-title":"Cognitive determinants of performance on the digit symbol-coding test, and the symbol search test of the WAIS-III, and the symbol digit modalities test: an analysis in a healthy sample","volume":"34","author":"Crowe","year":"1999","journal-title":"Aust Psychol"},{"key":"10.1016\/j.cct.2015.01.012_bb0175","first-page":"W32","article-title":"Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument","volume":"7","author":"Wagner","year":"2009","journal-title":"J Support Oncol"},{"key":"10.1016\/j.cct.2015.01.012_bb0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1037\/h0061266","article-title":"The Purdue pegboard; norms and studies of reliability and validity","volume":"32","author":"Tiffin","year":"1948","journal-title":"J Appl Psychol"},{"key":"10.1016\/j.cct.2015.01.012_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cct.2015.01.012_bb0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cct.2015.01.012_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.cct.2015.01.012_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures","volume":"27","author":"Hurst","year":"2004","journal-title":"J Manipulative Physiol Ther"},{"key":"10.1016\/j.cct.2015.01.012_bb0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jchromb.2007.11.019","article-title":"Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients","volume":"861","author":"Daali","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cct.2015.01.012_bb0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1570-0232(02)01042-5","article-title":"Determination of dextromethorphan and its metabolites in rat serum by liquid-liquid extraction and liquid chromatography with fluorescence detection","volume":"788","author":"Hendrickson","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cct.2015.01.012_bb0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cct.2015.01.012_bb0220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation","volume":"38","author":"Schmid","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cct.2015.01.012_bb0225","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1155\/2014\/507947","article-title":"Impaired modulation of pain in patients with postherpetic neuralgia","volume":"19","author":"Pickering","year":"2014","journal-title":"Pain Res Manag J Can Pain Soc"},{"key":"10.1016\/j.cct.2015.01.012_bb0230","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials","volume":"367","author":"Little","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2015.01.012_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0962280212445834","article-title":"The analysis of multivariate longitudinal data: a review","volume":"23","author":"Verbeke","year":"2014","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cct.2015.01.012_bb0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2015.01.012_bb0245","series-title":"Econometric models and economic forecasts","author":"Pindyck","year":"1998"},{"key":"10.1016\/j.cct.2015.01.012_bb0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14728214.2014.915025","article-title":"Emerging drugs for neuropathic pain","volume":"19","author":"Gilron","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.cct.2015.01.012_bb0255","first-page":"1507","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies","volume":"44","author":"Wolf","year":"2008","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.cct.2015.01.012_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing patient perceptions of the side effects of cancer chemotherapy","volume":"95","author":"Carelle","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2015.01.012_bb0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.cct.2015.01.012_bb0270","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.22610","article-title":"Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study","volume":"109","author":"Hermelink","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2015.01.012_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2354.2011.01320.x","article-title":"Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study","volume":"21","author":"Biglia","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.cct.2015.01.012_bb0280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11764-009-0098-x","article-title":"Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response","volume":"3","author":"Boykoff","year":"2009","journal-title":"J Cancer Surviv Res Pr"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714415000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714415000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:52:00Z","timestamp":1537923120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714415000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":56,"alternative-id":["S1551714415000245"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2015.01.012","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2015.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}